- Linkage Home
- Biospecimens: Advancing Epidemiologic Research
- Three Tenure-Track Investigators Join IIB
- Workshop Explores Low-Dose Radiation Epidemiology
- Fall 2008 Intramural Research Award Winners
- President's Cancer Panel Tackles Environmental Factors
- Study to Understand Cervical Cancer
- Bench-to-Bedside Award Targets Li-Fraumeni Syndrome
- Science Writers' Seminar on Genome-Wide Association Studies
- DCEG Assembles Two New Review Committees
- First Annual Fellows' Training Symposium
- DCEG Participates in the 100th Annual AACR Meeting
- Gloria Gridley Retires
- Transitions in the PLCO Study
- Pediatric Radiation Risks
- Workshop on Merkel Cell Carcinoma
- Richard Hayes Retires
- DCEG Holds Retreat for Tenure-Track Investigators
- New Representatives for Staff Scientist/Staff Clinician Organization
- Scientific Highlights
- DCEG People in the News
- Comings . . . Goings
- Director Receives Lifetime Achievement Award
Director Receives Lifetime Achievement Award
In April, Joseph F. Fraumeni, Jr., M.D., Division Director, received the American Association for Cancer Research (AACR) Award for Lifetime Achievement in Cancer Research in recognition of his seminal contributions to understanding the causes and prevention of human cancer. Established in 2004, this award honors an individual who has made lasting and significant fundamental contributions to cancer research, either through a single scientific discovery or a body of work, and has demonstrated a lifetime commitment to progress against cancer.
AACR President-elect Elizabeth Blackburn and Joseph Fraumeni
Dr. Fraumeni’s many accomplishments include the discovery and characterization of Li-Fraumeni syndrome, which bears his name along with that of his colleague Dr. Frederick P. Li, as well as the development of the U.S. Cancer Mortality Atlas project, which uses color-coded maps of cancer mortality at the county level to display high-risk areas. Epidemiologic studies carried out in these areas have uncovered a number of previously unrecognized carcinogenic hazards, including associations between oral cancer and smokeless tobacco in the South, lung cancer and asbestos exposure along coastal areas, lung cancer and inhaled arsenic among smelter workers and residents of surrounding communities, lymphoma and the use of agricultural herbicides in farming communities, nasal cancer and work in the furniture industry in the Southeast, and bladder cancer and certain occupational exposures as well as high levels of arsenic in drinking water in the Northeast. Many of these studies have led to cancer control measures, including labeling policies and educational campaigns for smokeless tobacco and regulatory limits for arsenic exposure.
Dr. Fraumeni’s epidemiological work has had a strong interdisciplinary orientation with clinical and laboratory components. He is the author of more than 800 scholarly papers and several books, and he continues to advance cancer research through his leadership and vision at the national and international levels. For more than 30 years, Dr. Fraumeni has been the architect of NCI’s research program in epidemiology, genetics, and related areas while developing fellowship programs designed to train and mentor the next generation of interdisciplinary scientists.
“I am delighted to receive this award, particularly as it comes from the world’s leading professional society devoted to cancer research,” Dr. Fraumeni said.
